Reuters logo
BRIEF-Colucid Pharmaceuticals says termination fee of $34 mln to be payable to Eli Lilly upon termination
January 18, 2017 / 1:42 PM / 8 months ago

BRIEF-Colucid Pharmaceuticals says termination fee of $34 mln to be payable to Eli Lilly upon termination

Jan 18 (Reuters) - Colucid Pharmaceuticals Inc :

* Colucid Pharmaceuticals - upon termination of deal under specified circumstances, co will be required to pay Eli Lilly termination fee of $34 million Source text (bit.ly/2jKbOWp) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below